에 대한 최신 뉴스 Quantum Computing (NASDAQ:QUBT) 주식

Quantum Computing

Quantum Computing Inc is an American company utilizing non-linear quantum optics (optical devices whose output due to quantum effects is exponentially, not linearly, related to inputs) to deliver quantum products for high-performance computing applications. QCi's products are designed to operate at room temperature and use low power at an affordable cost. The Company's portfolio of core technology and products offer new capabilities in the areas of high-performance computing, artificial intelligence, cyber security as well as remote sensing applications.

News

Movers

Tech

QUBT

퀀텀 컴퓨팅(NASDAQ:QUBT)의 주가가 수요일 급등하고 있다. 이 회사는 얇은 필름 리튬 나이오베이트(TFLN) 포토닉 칩 기술에 대한 첫 번째 확보된 주문을 발표하였으며, 이는 자사의 파운드리 서비스에 있어 이정표가 되는 사건이다. 다음은 알아야 할 사항이다.

퀀텀 컴퓨팅의 주식이 수요일 90% 이상 급등: 무슨 일이?

Quantum Computing Inc

WIIM

NVFY

Nova Lifestyle shares are trading higher after the company announced better-than-expected Q3 financials.

Earnings

TSSI

TSS Q3 EPS $0.10 Up From $0.01 YoY; Revenue $70.068M Up From $8.880M YoY

Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.08) by 175 percent. This is a 26.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $64.52 million which missed the analyst consensus estimate of $68.61 million by 5.97 percent. This is a 2.60 percent decrease over sales of $66.24 million the same period last year.

Earnings Misses

FLNT

Fluent Q3 Adj $(0.22) Misses $(0.08) Estimate, Sales $64.52M Miss $68.61M Estimate

If you've ever regretted eating that second gummy because the first one took forever to kick in, you're not alone. From unpredictable highs to hours of couch lock, the edible experience can be a minefield of bad trips. But Azuca is on a mission to change all that.
With a revolutionary whole-plant infusion process, Azuca's food-tech innovation standardizes the high. No solvents, no distillates—just a fast-acting, full-spectrum experience that finally delivers on the promise of predictable, enjoyable edibles.&nbsp;
In an exclusive interview with Benzinga Cannabis, CEO Kim Sanchez Rael shared how this innovation isn't just a win for consumers, it's a game changer for cannabis investors and edibles brands looking to stand out in a crowded market. 
"We've eliminated the typical pitfalls of the edibles segment," said Rael. "Our process offers a cleaner, more efficient path to product differentiation and profitability, all while delivering a superior experience to the end consumer."
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">A New Chapter In Edibles: Whole-Plant Infusion Without Extractions</h3>
One of the most significant breakthroughs from Azuca is its ability to <a href="https://feeds2.benzinga.com/markets/cannabis/24/04/38473652/inside-gr-ns-marijuana-edibles-factory-what-can-we-learn-about-choco-nomics-and-multi-state-expa">create edibles</a> using the entire cannabis flower without relying on extractions like distillate or resin. Traditional edible production involves extracting THC from the cannabis plant, often using solvents.&nbsp;
Meanwhile,<a href="https://www.benzinga.com/markets/cannabis/24/04/38093020/exclusive-why-wait-azuca-obx-speed-up-cannabis-access"> Azuca </a>utilizes the entire flower, delivering what Rael called a true "entourage effect" in an edible format. "We've made it possible to infuse edibles directly with cannabis flower, bypassing the need for any extraction. This means consumers get the full spectrum of the plant's compounds—<a href="https://www.benzinga.com/general/biotech/24/05/38626097/why-does-tangie-smell">cannabinoids, terpenes, and flavonoids</a>—in a consistent format. It's the closest experience to smoking the plant but without the need to inhale."
<h3 class="wp-block-heading">Ending The Bad Trip: Predictable Highs</h3>
Traditional<a href="https://feeds2.benzinga.com/markets/cannabis/24/08/40520617/detroits-first-cannabis-bakery-and-cafe-opens-soon-thc-cbd-infused-delights-await"> edibles</a> can take anywhere from 1 to 2 hours to kick in, leading many users to consume more than they should in frustration. The slow metabolization of THC in the liver can also produce a different, often more intense form of THC, which can result in a heavier, sedative effect—what the industry colloquially calls "couch lock."
Azuca's proprietary technology addresses this problem head-on. By encapsulating cannabis oil molecules in a starch-based shell, Azuca ensures that the cannabinoids are transformed into water-soluble compounds.&nbsp;
The encapsulation process allows the active ingredients to be absorbed rapidly in the mouth and upper digestive tract, bypassing the liver's delayed metabolization.
"Our technology delivers onset times as quick as 5 to 15 minutes," explained Rael. "This fast absorption not only prevents overconsumption but also offers a more predictable and sessionable experience, similar to smoking but in an <a href="https://feeds2.benzinga.com/markets/cannabis/24/10/41388261/revolutionizing-cannabis-edibles-ascends-new-thc-cannabinoid-blends-now-available-in-this-east-c">edible form</a>."
The encapsulation process also preserves the chemical integrity of the<a href="https://www.benzinga.com/markets/cannabis/23/12/36394288/cannabis-2024-experts-weigh-in-what-to-expect-from-dc-and-business-outlook-exciting-point-in-tim"> cannabinoids</a>, meaning that consumers experience THC in its Delta-9 form rather than the more intense 11-hydroxy-THC.&nbsp;
"We've effectively standardized the high," said Rael. "Gone are the days of nausea, anxiety, and unpredictable effects. Our products deliver a consistent, uplifting experience every time." While Azuca's technology aims to deliver a standardized, predictable experience,<a href="https://feeds2.benzinga.com/markets/cannabis/24/08/40121179/cannabis-edibles-gone-wrong-high-flyers-door-forcing-drama-and-assault-force-emergency-landing"> individual responses can still vary</a> based on dosage, personal tolerance and other factors.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/11/41948483/give-me-a-break-new-york-times-says-actor-jim-belushi-as-he-defends-cannabis-criticizes-big-pharma-food-industry"> &#8216;Give Me A Break, New York Times,&#8217; Says Actor Jim Belushi As He Defends Cannabis, Criticizes Big Pharma, Food Industry</a>
<h3 class="wp-block-heading">Starch Encapsulation: The Vanguard Of Food-Tech In Cannabis</h3>
Azuca's innovations are rooted in cutting-edge food technology, specifically the use of modified starches for encapsulating oil-based cannabinoids. Traditional methods of infusing <a href="https://feeds2.benzinga.com/markets/cannabis/24/08/40471578/mike-tysons-new-line-of-weed-gummies-now-available-in-colorado-heres-where-to-find-them-and-win-">edibles with THC</a> involve the use of sticky, viscous distillate, which can lead to significant waste and degradation of potency during the cooking process. Distillates are prone to transfer loss, cannabis oil sticking to mixing equipment, and oxidation from exposure to heat.
Azuca's encapsulation technique solves these issues. The proprietary starch coating not only makes the cannabinoids water-friendly but also prevents them from sticking to equipment, reducing waste.&nbsp;
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="731" height="1024" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13164839/Kim-Sanchez-Rael-headshot-cred_-Kim-Jew-731x1024.jpg" alt="" class="wp-image-646421" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13164839/Kim-Sanchez-Rael-headshot-cred_-Kim-Jew-731x1024.jpg 731w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13164839/Kim-Sanchez-Rael-headshot-cred_-Kim-Jew-214x300.jpg 214w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13164839/Kim-Sanchez-Rael-headshot-cred_-Kim-Jew-768x1076.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13164839/Kim-Sanchez-Rael-headshot-cred_-Kim-Jew.jpg 771w" sizes="(max-width: 731px) 100vw, 731px" /><figcaption class="wp-element-caption">Kim Sanchez Rael &#8211; headshot-cred_ Kim Jew</figcaption></figure>
According to Rael, the process reduces active ingredient loss by up to 20% during manufacturing, translating to significant cost savings for producers.
"Our starch encapsulation process is a game changer for the industry," Rael noted. "It protects the cannabinoids from degradation, ensuring potency, and allows for seamless integration into any <a href="https://feeds2.benzinga.com/markets/cannabis/24/08/40225540/summer-sizzles-with-thc-infused-beverages-market-report-reveals-top-selling-weed-drinks-in-u-s">edible product</a> without the need for additional extraction or emulsification equipment."
<h3 class="wp-block-heading">Scale And Market Reach</h3>
Azuca's business model is built on licensing its technology to cannabis brands and manufacturers. This approach has allowed the company to quickly <a href="https://feeds2.benzinga.com/markets/cannabis/24/06/39538627/from-local-startup-to-cannabis-edibles-powerhouse-cameron-saner-on-pushing-kosmik-brands-to-infi">scale and penetrate multiple markets</a> across the U.S. and Canada. The process is straightforward: Azuca supplies its proprietary Activator, a non-infused precursor, which manufacturers can easily mix with their cannabis input—whether it's distillate, live resin, or whole flower.
"Our model is designed to be scalable for any size operation," she said. "We have over 100 licensing agreements and have infused close to 2 billion milligrams of cannabinoids since our launch."
The Activator is available in different formulations tailored for various product types, including gummies, beverages, and chocolates. "We've made it easy for our partners to integrate our technology into their existing processes, without the need for heavy equipment or extensive training," Rael explained.
Read Also: <a href="https://www.benzinga.com/news/24/09/40941818/how-this-cheese-aging-tech-is-boosting-profits-for-cannabis-growers-stop-throwing-cheddar-out-the-do">How This Cheese-Aging Tech Is Boosting Profits For Cannabis Growers: Stop Throwing Cheddar Out The Door</a>
<h3 class="wp-block-heading">Financial Impact: Reduced Waste, Increased Profit Margins</h3>
Azuca's technology offers significant financial advantages for manufacturers. The reduction in waste during production not only improves efficiency but also boosts profitability. Products made with Azuca's technology often command a premium price in the marketplace.&nbsp;
"Consumers are willing to pay more for a product that offers a predictable, high-quality experience," said Rael. "We've seen premium pricing of 20% or more for fast-acting edibles, and up to a 50% premium for products that combine fast onset with functional effects like sleep or relaxation."
<h3 class="wp-block-heading">Beyond The Bud</h3>
While Azuca is focused on the cannabis industry, Rael sees potential applications for their encapsulation technology in other sectors, such as nutraceuticals. "This is fundamentally a substance delivery system. We're taking molecules that are difficult to metabolize and making them easy for the body to absorb. The same principles could apply to vitamins, supplements, and other active ingredients outside of cannabis."
By eliminating the need for extractions and delivering a fast, predictable, and enjoyable experience, Azuca is paving the way for a new generation of cannabis edibles.
"We're driven by innovation," Rael concluded. "Our mission is to raise the bar for what edibles can be and to provide a better experience for both consumers and manufacturers alike. This is just the beginning."
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40972472/x-rays-microwaves-and-now-what-this-company-freezes-weed-at-320-f-to-kill-mold-and-save-a-ton">X-Rays, Microwaves, And Now What? This Company Freezes Weed At -320°F To Kill Mold And Save A Ton</a>

Cannabis

Exclusives

Interview

Was The Whole Gummy Too Much? Azuca Solves The Cannabis Edibles Problem With Food-Tech

Earnings Beats

ALRN

Aileron Therapeutics Q3 EPS $(0.27) Beats $(0.41) Estimate

D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>) with a Buy and maintains $13 price target.

Price Target

Analyst Ratings

ENLV

D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target

Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) reported quarterly losses of $(0.45) per share. This is a 62.5 percent increase over losses of $(1.20) per share from the same period last year. The company reported $1.00 million in sales this quarter. This is a 70.49 percent decrease over sales of $3.39 million the same period last year.

Kidpik Q3 EPS $(0.45) Up From $(1.20) YoY, Sales $1.00M Down From $3.39M YoY

TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate.

TMC Metals Q3 2024 GAAP EPS $(0.06), Inline

HCW Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) reported $426.42 thousand in sales this quarter. This is a 50.02 percent decrease over sales of $853.10 thousand the same period last year.

HCWB

HCW Biologics Q3 Sales $426.42K Down From $853.10K YoY

AGFY

Agrify Q3 EPS $(17.31) Up From $(19.02) YoY; Revenue $1.934M Down From $3.139M YoY

Trading Ideas

BRK/A

POOL

SIRI

Berkshire Hathaway 13F Shows Added New Stake In Sirius XM Holdings With 105.16M Shares, Worth $2.49B; Added New Stake In Domino's Pizza With 1.28M Shares, Worth $549.4M; Added New Stake In Pool Corp With 404,057 Shares, Worth $152.2M

Berkshire Hathaway 13F Shows Increased Stake In American Express By 17% To 151.6M Shares, Now Worth $41.1B; Increased Stake In Kroger By 15% To 50M Shares, Worth $2.87B; Increased Stake In DaVita By 18%, Now Valued At $5.92B; Increased Stake In Moody's Corp By 13% To 24.67M Shares, Now Worth $11.71B

ROLR

High Roller Technologies Unaudited Q3 Revenue $7.52M Up From $5.80M QoQ

Telsey Advisory Group analyst Dana Telsey maintains European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) with a Outperform and maintains $8 price target.

EWCZ

Telsey Advisory Group Maintains Outperform on European Wax Center, Maintains $8 Price Target

CHTR

Berkshire Hathaway 13F Shows Reduced Stake In Bank Of America By 23% To 797.7M Shares, Worth $31.7B; Reduced Stake In Charter Communications By 26% To 2.82M Shares, Worth $914.5M; Reduced Stake In Nu Holdings By 19% To 86.4M Shares, Worth $1.18B; Reduced Stake In Occidental Petroleum By 18%, Now Valued At $13.16B

Consolidated Water Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.25 by 24 percent. The company reported quarterly sales of $33.391 million which beat the analyst consensus estimate of $31.750 million by 5.17 percent. This is a 33.02 percent decrease over sales of $49.854 million the same period last year.

CWCO

Consolidated Water Co Q3 2024 GAAP EPS $0.31 Beats $0.25 Estimate, Sales $33.391M Beat $31.750M Estimate

NMHI

Nature's Miracle Holding Q3 EPS $(0.09), Sales $3.05M Up From $2.69M YoY

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) with a Buy and maintains $9 price target.

KAPA

D. Boral Capital Maintains Buy on Kairos Pharma, Maintains $9 Price Target

<a href="https://truthsocial.com/@realDonaldTrump/113483513301208163" title="https://truthsocial.com/@realDonaldTrump/113483513301208163">https://truthsocial.com/@realDonaldTrump/113483513301208163</a>

Macro Notification

Politics

General

CORRECTION: Trump Picks Jay Clayton For U.S. Attorney For The Southern District Of New York

Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) shares are up 23.4% to $89.54 in November following the company's <a href="https://www.benzinga.com/news/earnings/24/11/41754359/astera-labs-stock-is-ripping-higher-today-whats-going-on">impressive third-quarter earnings</a> beat Wall Street expectations, reinforcing its role as a critical player in AI infrastructure. 
What To Know: Astera reported earnings of 23 cents per share, exceeding the estimated 17 cents, alongside revenue of $113.1 million, up 206% year-over-year and well above analyst forecasts of $97.4 million. 
CEO Jitendra Mohan highlighted that the company achieved its fifth consecutive quarter of record-breaking revenue, with sales rising 47% from the previous quarter, driven by new growth in AI connectivity solutions.
Astera's latest product, the Scorpio Smart Fabric Switch, is central to its strategy. These switches are designed to enhance data transfer speeds between GPUs, CPUs and storage devices, addressing critical needs in AI data centers where performance demands are skyrocketing.
Read Also: <a href="https://www.benzinga.com/tech/24/11/41973572/ray-dalios-bridgewater-cuts-stake-in-microsoft-stock-by-20-is-big-tech-losing-its-shine">Ray Dalio&#8217;s Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?</a>
What Else: The company's strong performance and promising product pipeline prompted multiple analysts to raise their price targets.
JPMorgan increased its target to $110 per share, while Deutsche Bank, Barclays and others <a href="https://www.benzinga.com/quote/ALAB/analyst-ratings">made upward revisions</a>. 
Astera's revenue forecast for the fourth quarter of $126–$130 million, alongside expected earnings of 25 cents to 26 cents per share, has added momentum to investor enthusiasm.
Read Also: <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">Disney Q4 Earnings: Revenue And Profit Beat, Best Film Studio Performance, 3-Year Outlook And More</a>
<h2 class="wp-block-heading">How To Buy ALAB Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Astera Labs&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, ALAB has a 52-week high of $100.09 and a 52-week low of $36.22.

ALAB

Astera Labs (ALAB) Stock Is Up 23% This Month: What's Going On?

Tech stocks were -12.2%, on average, last week as a result of the ISM manufacturing index reporting August figures below consensus expectations raising fears about the strength of the economy and the Federal Reserve cutting interest rates.

Our Quantum Computing Portfolio Was -9.8% Week-Ending September 6th

Our Pure-Play Quantum Computing Stocks Portfolio only includes those companies that concentrate all their efforts on the research and development of quantum computing.to allow for a true comparison of performance by similar constituents.

Update: Quantum Computing R&D Stocks Portfolio Up 3% This Week

Warning: QUBT is at high risk of performing badly

Quantum Computing GAAP EPS of -$0.06, revenue of $0.18M misses by $0.12M

Quantum Computing (QUBT) has reached the final stage of commissioning its quantum photonic chip foundry in Tempe, Arizona. Initially announced in S...

Quantum Computing's photonic chip foundry reaches final comissioning stage

Quantum Computing (QUBT) announced significant progress as it approaches the final commissioning of its quantum photonic chip foundry, set to open ...

Quantum Computing announces progress of quantum photonic chip foundry

Quantum Computing announces partnerships and pre-orders

Quantum Computing GAAP EPS of -$0.06, revenue of $0.1M

Quantum Computing Inc. (QUBT) Q3 2024 Shareholder Update Call Transcript

Quantum Computing ( ($QUBT) ) has released its Q3 earnings. Here is a breakdown of the information Quantum Computing presented to its investors. Qu...

Quantum Computing Inc. Reports Q3 2024 Financials

IONQ

QBTS

RGTI

Press Releases

Quantum Computing Inc. Announces Receipt of Nasdaq Non-Compliance Notice

Quantum Computing, Inc. Completes Restatement and Files Form 10-K/A for Fiscal Years 2023 and 2022

Contracts

Quantum Computing, Inc. Extends Collaborative Agreement with Los Alamos National Laboratory

Quantum Computing Inc. Reports Second Quarter and First Half 2024 Financial Results

Quantum Computing, Inc. Receives Award to Support NASA in Quantum Sensing Solutions for LiDAR Missions

Quantum Computing, Inc. Enters Final Stage of Commissioning Quantum Photonic Chip Foundry in Tempe, Arizona

Quantum Computing, Inc. to Host Third Quarter 2024 Shareholder Call on Wednesday, November 6, 2024

Quantum Computing, Inc. Announces Strategic Partnerships and Pre-Orders Ahead of 2025 Quantum Photonic Chip Foundry Opening

Quantum Computing Inc. Reports Third Quarter 2024 Financial Results

Quantum Computing, Inc. Secures First Order For TFLN Photonic Chip Foundry

AudioEye

iLearningEngines

Agora

Digital Turbine

CoreCard

Domo

Viant Technology

eGain

Expensify

Helport AI

Kaltura

CS Disco

Mercurity Fintech Holding Inc. - American Ordinary Shares

Mercurity Fintech Holding

ON24

Ooma

Perfect

Porch Group

Prairie Operating

D-Wave Quantum

Radcom

Rimini Street

Baijiayun Group Ltd - Class Ordinary Shares

Baijiayun Group

SoundThinking

Wellchange Holdings Company Limited - Ordinary shares

Wellchange Holdings

Ascendiant Capital

퀀텀 컴퓨팅(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>)의 주가가 수요일 급등하고 있다. 이 회사는 얇은 필름 리튬 나이오베이트(TFLN) 포토닉 칩 기술에 대한 첫 번째 확보된 주문을 발표하였으며, 이는 자사의 파운드리 서비스에 있어 이정표가 되는 사건이다. 다음은 <a href="https://www.benzinga.com/quote/QUBT/news">알아야 할 사항</a>이다.
주요 사항: 이 주문은 아시아의 저명한 연구 및 기술 기관에서 발주하였으며, 퀀텀의(QCi) 독점 TFLN 가공 전문 기술을 사용할 것이다. 이는 고성능 포토닉 집적 회로(PIC)와 통신 및 데이터 통신 시장에 필수적인 장치 생산에 중요하다.
첫 번째 포토닉 칩 납품은 2024년 12월로 예정되어 있으며, 2025년 1분기까지 완료될 것으로 예상된다.
&#8220;우리는 TFLN을 자사의 양자 기술에 통합함으로써 시스템의 정밀도와 성능을 향상시킬 수 있으며, QCi가 통합 포토닉스의 미래에 중요한 역할을 하게 되어 자랑스럽다. 포토닉스 커뮤니티가 TFLN을 계속 수용함에 따라 향후 몇 달 내에 추가 주문을 예상한다&#8221;고 QCi의 PICs 및 파운드리 서비스 이사인 포우야 다이아나 박사(Dr. Pouya Dianat)가 말했다.
QCi는 또한 두 개의 산업 파트너와 프로세스 설계 키트(PDK) 및 포토닉 칩 설계 서비스 개발을 위한 양해각서(MOU)를 최근 체결하였으며, 이는 2025년 1분기로 예정된 QCi 파운드리의 템피 애리조나 개장과 일치한다.
애널리스트 반응: 어센디언트 캐피털(Ascendiant Capital)의 애널리스트 에드워드 우(Edward Woo)는 QCi에 대한 &#8220;매수&#8221; 등급을 재확인하며, 목표 주가를 약간 상향 조정하여 $8.25에서 $8.50으로 상향 조정했다.
QUBT 주가 변동: QCi의 주가가 수요일 정규 거래에서 92.75% 급등 $2.66에 마감되었다 이후 시간외 거래에서 15.04% 추가 상승했다.
<a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" class="wp-image-646298" style="width: 415px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13152636/QUBT-1024x528.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13152636/QUBT-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13152636/QUBT-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13152636/QUBT-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13152636/QUBT.png 1467w" alt="" width="1024" height="528" /></a>
다음 읽어볼 기사:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41952244/michael-novogratz-bitcoin-reserve-could-push-price-to-500000-but-likelihood-is-low">마이클 노보그라츠: 비트코인 준비금이 가격을 $500,000로 올릴 수 있지만 가능성은 낮다.</a></li>
</ul>
사진 출처: Shutterstock

Comments

Quantum Computing

뉴스

에 대한 최신 뉴스 Quantum Computing (NASDAQ:QUBT) 주식

수요일, 11월 13, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌